Safety of Herceptin/Trastuzumab in Metastatic Breast Cancer

Clinical trial NCT02424682 · COMPLETED

Trial details

NCT number: NCT02424682
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer, Metastatic Breast Cancer

Start date: 2007-08-01
Primary completion: 2009-05-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.